Capital Advisors Ltd’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Capital Advisors Ltd's WST Position: Q3 2026 in Review
Capital Advisors Ltd increased its West Pharmaceutical (WST) stake by 63% in Q3 2026, buying an estimated $9.5K and bringing the position to 70 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #649.
Capital Advisors Ltd first reported a position in WST in Q4 2021 and has held it in 18 quarters since. 288 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Capital Advisors Ltd held 70 shares of West Pharmaceutical worth $26K as of Q3 2026.
- Capital Advisors Ltd bought 27 West Pharmaceutical shares in Q3 2026, an estimated $9.5K.
- West Pharmaceutical made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q3 2026, its #649 holding.
- Capital Advisors Ltd first reported a position in West Pharmaceutical in Q4 2021 and has held it in 18 quarters since.
- 288 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Capital Advisors Ltd's 13F filing for Q3 2026, filed 27 Oct 2026.